BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17540176)

  • 1. The tumor suppressor PP2A Abeta regulates the RalA GTPase.
    Sablina AA; Chen W; Arroyo JD; Corral L; Hector M; Bulmer SE; DeCaprio JA; Hahn WC
    Cell; 2007 Jun; 129(5):969-82. PubMed ID: 17540176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PP2A A subunits in tumor suppression.
    Sablina AA; Hahn WC
    Cell Adh Migr; 2007; 1(3):140-1. PubMed ID: 19262135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein phosphatase 2A is essential to maintain active Wnt signaling and its Aβ tumor suppressor subunit is not expressed in colon cancer cells.
    Carmen Figueroa-Aldariz M; Castañeda-Patlán MC; Santoyo-Ramos P; Zentella A; Robles-Flores M
    Mol Carcinog; 2015 Nov; 54(11):1430-41. PubMed ID: 25252130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PP2A: unveiling a reluctant tumor suppressor.
    Mumby M
    Cell; 2007 Jul; 130(1):21-4. PubMed ID: 17632053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PP2A Inactivation Mediated by
    Sents W; Meeusen B; Kalev P; Radaelli E; Sagaert X; Miermans E; Haesen D; Lambrecht C; Dewerchin M; Carmeliet P; Westermarck J; Sablina A; Janssens V
    Cancer Res; 2017 Dec; 77(24):6825-6837. PubMed ID: 29046336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.
    Tamaki M; Goi T; Hirono Y; Katayama K; Yamaguchi A
    Oncol Rep; 2004 Mar; 11(3):655-9. PubMed ID: 14767517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SV40 small T antigen and PP2A phosphatase in cell transformation.
    Sablina AA; Hahn WC
    Cancer Metastasis Rev; 2008 Jun; 27(2):137-46. PubMed ID: 18214640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of PP2A in viral and cellular transformation.
    Arroyo JD; Hahn WC
    Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple pathways regulated by the tumor suppressor PP2A in transformation.
    Westermarck J; Hahn WC
    Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer.
    Kauko O; Westermarck J
    Int J Biochem Cell Biol; 2018 Mar; 96():157-164. PubMed ID: 29355757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
    Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
    Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ral GTPases: corrupting the exocyst in cancer cells.
    Camonis JH; White MA
    Trends Cell Biol; 2005 Jun; 15(6):327-32. PubMed ID: 15953551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
    Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R
    Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
    Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
    Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
    Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
    Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase 2A Aα regulates Aβ protein expression and stability.
    O'Connor CM; Hoffa MT; Taylor SE; Avelar RA; Narla G
    J Biol Chem; 2019 Apr; 294(15):5923-5934. PubMed ID: 30796164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B56γ tumor-associated mutations provide new mechanisms for B56γ-PP2A tumor suppressor activity.
    Nobumori Y; Shouse GP; Wu Y; Lee KJ; Shen B; Liu X
    Mol Cancer Res; 2013 Sep; 11(9):995-1003. PubMed ID: 23723076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glycine 90 to aspartate alteration in the Abeta subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function.
    Esplin ED; Ramos P; Martinez B; Tomlinson GE; Mumby MC; Evans GA
    Genes Chromosomes Cancer; 2006 Feb; 45(2):182-90. PubMed ID: 16276521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin extracts the Ras family protein RalA from lipid bilayers by engagement with two membrane-targeting motifs.
    Chamberlain SG; Gohlke A; Shafiq A; Squires IJ; Owen D; Mott HR
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells.
    Zhu X; Li Y; Luo X; Fei J
    Cell Signal; 2012 Jun; 24(6):1134-40. PubMed ID: 22330069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.